339 related articles for article (PubMed ID: 29235363)
1. Phenotypic screening approaches for Chagas disease drug discovery.
Chatelain E; Ioset JR
Expert Opin Drug Discov; 2018 Feb; 13(2):141-153. PubMed ID: 29235363
[TBL] [Abstract][Full Text] [Related]
2. Animal models of Chagas disease and their translational value to drug development.
Chatelain E; Scandale I
Expert Opin Drug Discov; 2020 Dec; 15(12):1381-1402. PubMed ID: 32812830
[TBL] [Abstract][Full Text] [Related]
3. Advances in preclinical approaches to Chagas disease drug discovery.
Villalta F; Rachakonda G
Expert Opin Drug Discov; 2019 Nov; 14(11):1161-1174. PubMed ID: 31411084
[No Abstract] [Full Text] [Related]
4. Novel drug discovery for Chagas disease.
Moraes CB; Franco CH
Expert Opin Drug Discov; 2016; 11(5):447-55. PubMed ID: 26967915
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.
Ekins S; de Siqueira-Neto JL; McCall LI; Sarker M; Yadav M; Ponder EL; Kallel EA; Kellar D; Chen S; Arkin M; Bunin BA; McKerrow JH; Talcott C
PLoS Negl Trop Dis; 2015; 9(6):e0003878. PubMed ID: 26114876
[TBL] [Abstract][Full Text] [Related]
6. Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
Riley J; Brand S; Voice M; Caballero I; Calvo D; Read KD
PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004014. PubMed ID: 26394211
[TBL] [Abstract][Full Text] [Related]
7. Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).
Rodriguez JB; Falcone BN; Szajnman SH
Expert Opin Ther Pat; 2016 Sep; 26(9):993-1015. PubMed ID: 27376456
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery for chagas disease: A viewpoint.
Kratz JM
Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
[TBL] [Abstract][Full Text] [Related]
9. Current advances in drug discovery for Chagas disease.
Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
[TBL] [Abstract][Full Text] [Related]
10. New drug discovery strategies for the treatment of benznidazole-resistance in
Murta SMF; Lemos Santana PA; Jacques Dit Lapierre TJW; Penteado AB; El Hajje M; Navarro Vinha TC; Liarte DB; de Souza ML; Goulart Trossini GH; de Oliveira Rezende Júnior C; de Oliveira RB; Ferreira RS
Expert Opin Drug Discov; 2024 Jun; 19(6):741-753. PubMed ID: 38715393
[TBL] [Abstract][Full Text] [Related]
11. Chagas disease drug discovery: toward a new era.
Chatelain E
J Biomol Screen; 2015 Jan; 20(1):22-35. PubMed ID: 25245987
[TBL] [Abstract][Full Text] [Related]
12. Why hasn't there been more progress in new Chagas disease drug discovery?
Vermelho AB; Rodrigues GC; Supuran CT
Expert Opin Drug Discov; 2020 Feb; 15(2):145-158. PubMed ID: 31670987
[No Abstract] [Full Text] [Related]
13. Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box.
Cantizani J; Gamallo P; Cotillo I; Alvarez-Velilla R; Martin J
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009602. PubMed ID: 34270544
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity.
Zingales B; Miles MA; Moraes CB; Luquetti A; Guhl F; Schijman AG; Ribeiro I; ;
Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):828-33. PubMed ID: 25317712
[TBL] [Abstract][Full Text] [Related]
15. Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery.
Mansoldo FRP; Carta F; Angeli A; Cardoso VDS; Supuran CT; Vermelho AB
Molecules; 2020 Nov; 25(22):. PubMed ID: 33238613
[TBL] [Abstract][Full Text] [Related]
16. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
17. Lead identification to clinical candidate selection: drugs for Chagas disease.
Neitz RJ; Chen S; Supek F; Yeh V; Kellar D; Gut J; Bryant C; Gallardo-Godoy A; Molteni V; Roach SL; Khare S; Stinson M; Chatterjee AK; Robertson S; Renslo AR; Arkin M; Glynne R; McKerrow J; Siqueira-Neto JL
J Biomol Screen; 2015 Jan; 20(1):101-11. PubMed ID: 25281737
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Strong 3-Nitro-2-Phenyl-
Carey SM; O'Neill DM; Conner GB; Sherman J; Rodriguez A; D'Antonio EL
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673904
[TBL] [Abstract][Full Text] [Related]
19. Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery.
MacLean LM; Thomas J; Lewis MD; Cotillo I; Gray DW; De Rycker M
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006612. PubMed ID: 30001347
[TBL] [Abstract][Full Text] [Related]
20. High throughput screening for anti-Trypanosoma cruzi drug discovery.
Alonso-Padilla J; Rodríguez A
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3259. PubMed ID: 25474364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
